文档介绍：通心络联合辛伐他汀治疗脂肪肝126例临床疗效分析

该论文来源于网络，本站转载的论文均是优质论文，供学****和研究使用，文中立场与本网站无关，版权和著作权归原作者所有，如有不愿意被转载的情况，请通知我们删除已转载的信息，如果需要分享，请保留本段说明。
　　[摘要] 目的研究通心络联合辛伐他汀治疗脂肪肝（非酒精性）患者的临床疗效观察。方法方便选取2018年1月—2019年6月该院就诊非酒精性脂肪肝患者共126例，随机分为观察组和对照组，每组63例，对照组给予辛伐他汀治疗，观察组给予通心络联合辛伐他汀治疗，对比两组患者治疗效果。结果从治疗有效率分析，观察组总有效率（%）高于对照组（%）;从不良反应率分析，观察组治疗期间不良反应率（%）显著低于对照组（%）（χ2=，P=）;血脂指标结果显示，治疗前观察组TG、TC、LDL-C和HDL-C水平与对照组差异无统计学意义（P>），治疗后LDL-C水平相比于对照组明显偏高，而TG、TC、HDL-C水平较对照组明显降低（P<）。结论通心络联合辛伐他汀治疗脂肪肝能明显降低患者不良反应率，改善患者血脂水平，提高临床疗效。
　　[关键词] 通心络;辛伐他汀;脂肪肝;临床疗效
　　[中图分类号] [文献标识码] A [文章编号] 1674-0742（2020）06（b）-0121-03
　　[Abstract] Objective To study the clinical efficacy of Tongxinluo combined with simvastatin in the treatment of fatty liver （non-alcoholic） patients. Methods Convenient selection of 126 patients with non-alcoholic fatty liver treated in the hospital from January 2018 to June 2019 were randomly divided into an observation group and a control group， with 63 cases in each group. The control group was treated with simvastatin and the observation group Tongxinluo combined with simvastatin treatment was given to compare the treatment effect of the two groups of patients. Results From the analysis of treatment efficiency， the total effective rate of the observation group （%） was higher than that of the control group （%）（χ2=，P=）; from the analysis of adverse reaction rate， the adverse reaction rate of the observation group during treatment （%）， significantly lower than the control group （%）; blood lipid index results showed that the levels of TG， TC， LDL-C and HDL-C in the observation group before treatment were not statistically significantly different from the control group（P>）， the level of LDL-C was significantly higher than that of the control group after treatment， while the levels of TG， TC， HDL-C were significantly lower than that of the control group（P<）.